ArticlePharmacology research & perspectives2017

PDE4 inhibitor rolipram inhibits the expression of microsomal prostaglandin E synthase-1 by a mechanism dependent on MAP kinase phosphatase-1.

Lauri Tuure et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.